MDT Medtronic plc

  1. Stocks
  2. Healthcare
  3. NYSE: MDT

Price (delayed)

$81.19

Market cap

$104.24B

P/E Ratio

22.55

Dividend/share

$2.84

EPS

$3.6

Enterprise value

$131.16B

?
Relative Growth: Rel. Growth: 49
Relative Strength: Rel. Strength: 22
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 71

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
Medtronic's quick ratio has increased by 30% YoY and by 4.7% from the previous quarter
The price to earnings (P/E) is 24% lower than the 5-year quarterly average of 28.4 and 15% lower than the last 4 quarters average of 25.5
The EPS rose by 9% year-on-year but it has declined by 3.2% since the previous quarter
The net income has grown by 8% YoY but it has contracted by 3.2% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.medtronic.com
Peers: BSX SYK EW JNJ

Key stats

What are the main financial stats of MDT

MDT stock price

How has the Medtronic stock price performed over time
Intraday
4.16%
1 week
7.44%
1 month
3.69%
1 year
-5.15%
YTD
-15.48%
QTD
-6.3%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$35.48B
Gross profit
$23.01B
Operating income
$6.03B
Net income
$4.61B
Gross margin
64.9%
Net margin
13%
The operating income has increased by 8% YoY but it has decreased by 2.9% QoQ
The net income has grown by 8% YoY but it has contracted by 3.2% from the previous quarter
Medtronic's revenue has increased by 7% YoY and by 2.1% from the previous quarter
MDT's gross profit is up by 6% year-on-year

Price vs fundamentals

How does MDT's price correlate with its fundamentals

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
MDT P/E details
P/E
22.55
P/B
2.12
P/S
2.93
EV/EBIT
20.99
EV/EBITDA
14.06
EV/Sales
3.7
The price to earnings (P/E) is 24% lower than the 5-year quarterly average of 28.4 and 15% lower than the last 4 quarters average of 25.5
The EPS rose by 9% year-on-year but it has declined by 3.2% since the previous quarter
The stock's price to book (P/B) is 18% less than its last 4 quarters average of 2.5 and 15% less than its 5-year quarterly average of 2.4
MDT's P/S is 26% lower than its 5-year quarterly average of 3.8 and 19% lower than its last 4 quarters average of 3.5
Medtronic's revenue has increased by 7% YoY and by 2.1% from the previous quarter

Efficiency

How efficient is Medtronic business performance
Medtronic's return on equity has increased by 9% YoY but it has decreased by 3.1% QoQ
MDT's return on assets is up by 6% year-on-year but it is down by 3.8% since the previous quarter
The company's return on invested capital fell by 5% QoQ and by 3.4% YoY
The return on sales has declined by 4.3% since the previous quarter

Dividends

What is MDT's dividend history
Dividend details
DPS
$2.84
Dividend yield
3.5%
Payout ratio
78.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Medtronic financials performed over time
The total assets is 116% greater than the total liabilities
The company's current ratio rose by 34% YoY and by 5% QoQ
Medtronic's quick ratio has increased by 30% YoY and by 4.7% from the previous quarter
MDT's debt is 43% smaller than its equity
MDT's debt is up by 6% year-on-year but it is down by 3.5% since the previous quarter
Medtronic's debt to equity has increased by 6% YoY but it has decreased by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.